[Oral estro-progestational agents and the uterine cervix].
D000293:Adolescent; D000328:Adult; D001706:Biopsy; D002277:Carcinoma / Q000139:chemically induced* / Q000473:pathology; D002278:Carcinoma in Situ / Q000139:chemically induced* / Q000473:pathology; D002584:Cervix Uteri / Q000473:pathology; D003276:Contraceptives, Oral / Q000008:administration & dosage / Q000009:adverse effects*; D004847:Epithelial Cells; D004848:Epithelium / Q000187:drug effects; D004967:Estrogens / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged; D011247:Pregnancy; D011372:Progestins / Q000008:administration & dosage / Q000009:adverse effects*; D002577:Uterine Cervical Diseases / Q000139:chemically induced* / Q000473:pathology; D002583:Uterine Cervical Neoplasms / Q000139:chemically induced* / Q000473:pathology
D003276:Contraceptives, Oral; D004967:Estrogens; D011372:Progestins
Oestro-progestatifs oraux et col uterin.